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Introduction Infantile haemangioma (IH) is a very common vascular
tumour that affects up to 10% of newborns. Since 2008, oral propranolol is
used to treat complicated IH, like haemangioma that obstruct vital structures
or ulcerated haemangioma.
Objective The aim of this study was to investigate, by a retrospective
review, the therapeutic results and effects of propranolol on cardiovascular
and biological parameters in infants treated for complicated infantile haeman-
gioma and to assess its safety.
Results All paediatric patients with complicated IH who started systemic pro-
pranolol from February 2009 to December 2014 were included. 218 patients
(155 girls and 63 boys) were treated by propranolol. The mean weight was
6780 g (2115 g to 20 000 g). Median age at beginning of treatment was
4.7 months (10 days to 6 years). The most frequent localisation of IH was facial
(63 patients), palpebral (52 patients), perineal (20 patients), labial (14 patients),
airway obstruction (8 patients) and 1 PHACE syndrome. Median length of
therapy was 7.5 months for facial IH, 6 months for palpebral, 5.6 months for
perineal IH and 7 months for subglottic localisation. Adverse events were
observed: hypoglycaemia (n = 11 patients aged less 6 months), arterial hypo-
tension (n=103 patients, especially at the second and third dose with dose titra-
tion), bradycardia (n=120). Transthoracic echocardiography was realised in
158 patients: 19 pathologies was found (8 PDA, 4 ASD, 4 mitral regurgitations,
2 VSD, 1 coarctation). Other adverse events occurred in 49 patients (wheezing,
acrocyanosis, diarrhoea, sleep disturbance) leading to modification in manage-
ment. Complete response was observed for all but 11 (partial or no response).
Conclusion In appropriated patients, propranolol therapy is effective for
severe or complicated IH. We must be aware of frequent adverse events under
beta-blocker in these patients.
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Background Cardiac catheterization in infants is associated with Adverse
Event (AE) or mortality in Congenital Heart Disease (CHD). AE levels and
procedure type risk categories (PTRC) have been defined using the previously
reported CHARM study.
Aim To investigate factors associated to AE and outcome using PTRC and
a new hemodynamic vulnerability index (HVI) in a Caribbean catheter lab.
Methods Retrospective longitudinal records from 2007 to 2014 in all
consecutive infants <1 year admitted for elective or urgent cardiac procedure
(CP), either diagnostic (CPD) or interventional (CPI). Demographics, CHD’s,
non – cardiac problems, PTRC, HVI, AE, transfusion, 30-day and mid-term
mortality were analysed.
Results 120 consecutive infants (age: 121.3 ± 91.5, median 126, 0-340
days, weight: 4.54 ± 1.6, median 4.6, 1-9 Kg) were included, with 32% of
PTRC ≥3 (p<0.001), 80 (66%) of CPI (95% of success), and 12.5% of trans-
fusion. Among all CP’s, 39 (32 CPI) were urgent or rescue, and 27% had a
HVI≥3. Significant AE (level ≥3) were noted in 11 (9,2%) cases (6 of level 5,
and 5 strictly related to admission status), with 2 AE requiring surgery. CPI
(7<2.5 Kg, 4<1.5 kg) covered almost all types of intervention. One CPI
directly related death was noted, but 30 – day mortality was 7.5% and mid-
term mortality 15%. Urgent CP had higher PTRC (p<0.001), HVI (p<0.02),
and mortality (p<0.001) but lower weight (p<0.02) than elective. Severe AE
were associated with urgent or rescue CP (p<0.005), transfusion (p=0.005),
30-day and mortality (p<0.001). Mortality was also linked (p<0.001) with sec-
ondary elective surgery, some CPD types (CHARM classification), lower
weight (30-day mortality only, p=0.03), and pulmonary valvuloplasty (30 – day
mortality only, p<0.001).
Conclusion CP <1 year was often urgent and at high risk with a reasonable
number of significant AE’s and a low CP related death rate. Admission status,
30-day mortality, and weight <2 kg need a careful attention.
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Introduction In EA, both atrialised and functional components of the right
ventricle are exposed to high preload and low afterload. The Cone operation
enables to eliminate tricuspid regurgitation (TR) and reposition tricuspid valve
to its anatomic annulus. The aim of the study was to investigate the adaptation
of right (RV) and left ventricles (LV) to change in loading conditions after
Cone repair.
Methods A retrospective longitudinal study was conducted from 2009
to 2014. All symptomatic patients with moderate to severe TR were
included. Transthoracic advanced echocardiography was performed pre-
operatively, at short-term (less than 30 days after Cone repair) and mid-term
(17±11 months). Conventional parameters, the systolic peak of longitudinal
2D strain and the time to peak systolic Strain were measured for LV and
RV. Paired t-test analyses were performed using Wilcoxon Matched-pairs
signed rank test.
Results From the 38 patients operated for EA, the echocardiographic data
of 17 patients could be analysed. GOSH score was significantly reduced after
Cone repair (1.07±0.24 vs. 0.30±0.07, p=0.020) as well as TR (3.53±0.24 vs.
1.18±0,37, p=0.003). However, the TAPSE (26.42±5.79 vs. 5.78±2.00,
p=0.005), LV and RV systolic peaks were significantly reduced post-
operatively (–19.80±1.05 vs. –15.85±1.13, p<0.001 for LV, –18.50±1.80 vs.
– 13.53±1.52, p<0.001 for RV), but with no significant reduction between pre-
operative and mid-term post-operative period (– 19.80±1.05 vs. – 21.86±1.90,
p=0.677 for LV, –18.50±1.80 vs. –18.74.50±1.80 vs. 3.66, p=0.285 for RV).
LV time to peak was significantly reduced in short-term post-operative period
(441±9 vs. 415±11, p<0.001).
Conclusion The rapid change in loading conditions following Cone opera-
tion reduces myocardial contractility of both ventricles but with the trend to
later recovery. LV myocardial mechanics appears better than preoperatively.
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